Sunshine Biopharma Inc (SBFM) — Working Capital to Net Assets Ratio
Sunshine Biopharma Inc (SBFM) has a Working Capital to Net Assets ratio of 88.6% as of March 2026. Working capital of $20.41 Million (current assets of $26.85 Million minus current liabilities of $6.44 Million) is measured against net assets of $23.04 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Sunshine Biopharma Inc net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Sunshine Biopharma Inc Working Capital to Net Assets (2007–2025)
This chart shows how Sunshine Biopharma Inc's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of March 2026, the ratio stands at 88.6%, reflecting working capital of $20.41 Million against net assets of $23.04 Million USD. Check SBFM tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Sunshine Biopharma Inc (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Sunshine Biopharma Inc from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see SBFM market cap.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 88.6% | $20.41 Million | $23.04 Million | $26.85 Million | $6.44 Million | ▲ +5.0 pp |
| 2024 | 83.6% | $19.65 Million | $23.50 Million | $25.97 Million | $6.31 Million | ▼ -7.6 pp |
| 2023 | 91.2% | $19.34 Million | $21.21 Million | $24.89 Million | $5.55 Million | ▼ -3.1 pp |
| 2022 | 94.2% | $20.38 Million | $21.63 Million | $27.31 Million | $6.93 Million | ▼ -900.1 pp |
| 2021 | 994.3% | $2.10 Million | $211.66K | $2.20 Million | $91.23K | ▲ +991.7 pp |
| 2020 | 2.7% | $-25.36K | $-954.84K | $1.03 Million | $1.05 Million | ▼ -101.8 pp |
| 2019 | 104.4% | $-767.84K | $-735.38K | $65.69K | $833.53K | ▼ -1152.9 pp |
| 2018 | 1257.3% | $-700.97K | $-55.75K | $211.51K | $912.48K | ▲ +1146.7 pp |
| 2017 | 110.6% | $-633.94K | $-573.36K | $117.20K | $751.14K | ▲ +7.7 pp |
| 2016 | 102.8% | $-215.64K | $-209.70K | $58.46K | $274.10K | ▼ -100.9 pp |
| 2015 | 203.7% | $-1.22 Million | $-597.04K | $53.91K | $1.27 Million | ▲ +103.7 pp |
| 2014 | 100.0% | $-387.58K | $-387.58K | $143.42K | $531.00K | ▲ +0.0 pp |
| 2013 | 100.0% | $-7.71K | $-7.71K | $31.24K | $38.95K | ▲ +0.0 pp |
| 2012 | 100.0% | $70.43K | $70.43K | $134.79K | $64.37K | ▲ +0.0 pp |
| 2011 | 100.0% | $103.00K | $103.00K | $106.44K | $3.43K | ▲ +0.0 pp |
| 2010 | 100.0% | $196.22K | $196.22K | $207.62K | $11.40K | ▲ +0.0 pp |
| 2009 | 100.0% | $97.80K | $97.80K | $112.12K | $14.31K | ▲ +0.0 pp |
| 2008 | 100.0% | $-17.71K | $-17.71K | $5.03K | $22.74K | ▲ +0.0 pp |
| 2007 | 100.0% | $13.39K | $13.39K | $14.89K | $1.50K | — |